US Stocks
/
Iovance Biotherapeutics, Inc. Share Price

Iovance Biotherapeutics, Inc. Share Price

NASDAQ: IOVA | Micro Cap
$14.61
+$1.26 (9.44%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Iovance Biotherapeutics, Inc. Stock Performance

Open
$13.39
Prev. Close
$13.35
Circuit Range
N/A
Day Range
$13.31 - $14.94
Year Range
$1.76 - $15.30
Volume
10,82,009
Average Traded
$14.46

Iovance Biotherapeutics, Inc. Share Price Today

As of 11 October 2026, Iovance Biotherapeutics, Inc.'s share price is $14.61. The stock opened at $13.39, compared to its previous close of $13.35. During today's trading session, Iovance Biotherapeutics, Inc.'s share price traded between $13.31 and $14.94, with an average price of $14.12. Over the past 52 weeks, the stock has recorded a high of $15.30 and a low of $1.76. In terms of performance, Iovance Biotherapeutics, Inc.'s share price has risen by 336.12% over the last six months and is up 645.41% on a year-on-year basis.

Iovance Biotherapeutics, Inc. Share Price Chart

$13.31$14.94
L
Show Current Price
H

Iovance Biotherapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$5.22M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.64
Revenue (TTM)
$263.50B
Return On Equity (TTM)
-39.33%
Profit Margin
-148.38%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
48.14%

Iovance Biotherapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$67.46$86.77$71.43$99.31
Net Profit-$91.25-$71.90-$79.05-$47.32
Net Profit Margin-135.27%-82.86%-110.67%-47.65%
Income ChangeN/A21.21%-9.94%40.14%

Iovance Biotherapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$1.19$164.07$263.50
Net Profit-$395.89-$444.04-$372.18-$390.98
Net Profit MarginN/A-37314.29%-226.84%-148.38%
Income ChangeN/A-12.16%16.18%-5.05%

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Iovance Biotherapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$14.76
$14.63
-1.32%
Sep 2026
$8.02
$14.82
+79.20%
Aug 2026
$4.11
$8.27
+103.74%
Jul 2026
$4.17
$4.06
-2.43%
Jun 2026
$4.15
$4.16
+1.46%
May 2026
$3.37
$4.10
+22.39%
Apr 2026
$3.60
$3.35
-4.56%
Mar 2026
$3.67
$3.51
-9.54%
Feb 2026
$2.53
$3.88
+52.76%
Jan 2026
$2.78
$2.54
-6.96%
Dec 2025
$2.40
$2.73
+10.75%
Nov 2025
$2.15
$2.46
+25.77%

IOVA Share Price FAQs

What is Iovance Biotherapeutics, Inc. share price today?

chevron-up
Iovance Biotherapeutics, Inc. share price today is $14.61 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Iovance Biotherapeutics, Inc. stock?

chevron-up
The 52 week high of Iovance Biotherapeutics, Inc. stock is $15.30, while the 52 week low is $1.76 as of 10 Oct '26.

What is IOVA's market capitalisation today?

chevron-up
IOVA market capitalisation is $5.22M as of October 11, 2026, at 12:26 am IST.

What is IOVA's net income for the last quarter?

chevron-up
IOVA's net income for the last quarter is -47.32B USD.

What is the 5 year returns of IOVA?

chevron-up
The 5 year returns of IOVA is -39.90% as on 10 Oct '26.

What is the high & low stock price of IOVA today?

chevron-up
IOVA stock price hit a high of $14.94 and low of $13.31 as of 10 Oct '26.

Can I buy IOVA shares in India?

chevron-up
Yes. You can buy IOVA in India by opening an international trading account.